Eszopiclone
Back to searchMolecule Structure
Scientific Name
Eszopiclone
Description of the Drug
Eszopiclone is a sedative-hypnotic used in the treatment of insomnia, improving both the latency phase and the maintenance phase of sleep.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00402
http://www.drugbank.ca/drugs/DB00402
Brand Name(s)
Eszopiclone, Lunesta
Company Owner(s)
Nostrum Laboratories Inc, Teva Pharmaceuticals Usa Inc, Glenmark Generics Ltd, Macleods Pharmaceuticals Ltd, Sun Pharmaceutical Industries Ltd, Chartwell Rx Sciences Llc, Sunovion Pharmaceuticals Inc, Aurobindo Pharma Ltd, Dr Reddys Laboratories Ltd, Orbion Pharmaceuticals Private Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| GABA-A receptor; anion channel | PROTEIN COMPLEX GROUP | POSITIVE ALLOSTERIC MODULATOR | CHEMBL2093872 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL28657 | |
| PharmGKB | PA162630444 | |
| Human Metabolome Database | HMDB0014546 | |
| DrugBank | DB00402 | |
| PubChem: Thomson Pharma | 14927588 | |
| PubChem | 969472 | |
| Mcule | MCULE-5099990703 | MCULE-3167182309 |
| Nikkaji | J573.434G | |
| BindingDB | 50247998 | |
| EPA CompTox Dashboard | DTXSID8046086 | |
| DrugCentral | 1068 | |
| ChemicalBook | CB1468825 | |
| Guide to Pharmacology | 7429 | |
| rxnorm | ESZOPICLONE | LUNESTA |
| PubChem: Drugs of the Future | 12015386 | |
| ChEBI | 53760 | |
| ZINC | ZINC000019632834 |
